HealOr names Dr Michael Sabolinski CEO
This article was originally published in Scrip
HealOr, a speciality biopharmaceutical company developing topical therapeutics for treating chronic wounds such as diabetic foot ulcer, has named Dr Michael Sabolinski chief executive officer. Dr Sabolinski has 25 year's experience in wound-care research, and was previously HealOr's chief medical officer. Prior to HealOr, he served as Organogenesis' president and CEO.